机译:除了P2Y12抑制外,急性冠状动脉综合征(Gemini-ACS-1)外,用低剂量蓖麻毒素与阿司匹林出血的临床显着的出血:双盲,多期,随机试验
Duke Univ Sch Med Duke Clin Res Inst Durham NC USA;
Duke Univ Sch Med Duke Clin Res Inst Durham NC USA;
Univ Paris Diderot AP HP DHU FIRE Paris France;
Uppsala Univ Dept Med Sci Uppsala Sweden;
Duke Univ Sch Med Duke Clin Res Inst Durham NC USA;
Duke Univ Sch Med Duke Clin Res Inst Durham NC USA;
Duke Univ Sch Med Duke Clin Res Inst Durham NC USA;
Janssen Res &
Dev Raritan NJ USA;
Bayer AG Wuppertal Germany;
Janssen Res &
Dev Raritan NJ USA;
Janssen Res &
Dev Raritan NJ USA;
Aarhus Univ Hosp Dept Cardiol Aarhus Denmark;
Med Univ Silesia Div Cardiol 3 Katowice Poland;
Grp Hosp Pitie Salpetriere Inst Cardiol Paris France;
INECO Neurociencias Orono Rosario Santa Fe Argentina;
Policlin San Matteo Div Cardiol Pavia Italy;
Spanish Natl Ctr Cardiovasc Res Madrid Spain;
Univ Antwerp Hosp Edegem Belgium;
Univ Sao Paulo Med Sch Heart Inst InCor Sao Paulo Brazil;
Noordwest Ziekenhuisgrp Alkmaar &
Dutch Network C Dept Cardiol Alkmaar Netherlands;
Tokai Univ Sch Med Dept Med Cardiol Isehara Kanagawa Japan;
Mil Hosp Dept Cardiol Budapest Hungary;
Numune Educ &
Res Hosp Dept Cardiol Ankara Turkey;
Univ Ulsan Coll Med Asan Med Ctr Div Cardiol Seoul South Korea;
Univ Freiberg Freiburg Germany;
Mazankowski Alberta Heart Inst Edmonton AB Canada;
Harvard Med Sch Beth Israel Deaconess Hosp PERFUSE Study Grp Boston MA USA;
机译:除了P2Y12抑制外,急性冠状动脉综合征(Gemini-ACS-1)外,用低剂量蓖麻毒素与阿司匹林出血的临床显着的出血:双盲,多期,随机试验
机译:对于急性冠脉综合征进行经皮冠状动脉介入治疗的患者,双剂量vs标准剂量氯吡格雷和大剂量vs低剂量阿司匹林(CURRENT-OASIS 7):一项随机因子试验。
机译:利伐沙班与安慰剂治疗急性冠状动脉综合征(ATLAS ACS-TIMI 46):一项随机,双盲,II期临床试验。
机译:稳定型缺血性心脏病和急性冠脉综合征(LILACS)患者的小剂量白细胞介素2:一项随机双盲安慰剂对照的I / II期临床试验的方案和研究依据
机译:一项随机试验比较利伐沙班和阿司匹林除氯吡格雷或替格瑞洛在急性冠脉综合征中的安全性:GEMINI-ACS-1 II期研究的设计